BioSpace News Archive

United Therapeutics Corporation, a public benefit corporation, announced that Patrick Poisson, Executive Vice President, Technical Operations, will provide an overview and update on the company’s operations during a fireside chat session at the Leerink Partners Global Biopharma Conference 2024 in Miami Beach, Florida.

Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, announced the data from a successful Phase Ib/IIa trial for lead candidate EXN407.

Notable Labs, Ltd. announced that the Company will present two posters related to its PPMP platform at the American Association for Cancer Research Annual Meeting 2024, taking place April 5-10, 2024 in San Diego, CA.

Apogee Therapeutics, Inc., a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease, asthma and other inflammatory and immunology indications, reported pipeline highlights and fourth quarter and full year 2023 financial results.

Zomedica Corp. announced that Larry Heaton, Chief Executive Officer, will present and host one-on-one meetings with investors at the Sidoti Small Cap Conference, taking place virtually on March 14th, 2024.

Merck, known as MSD outside of the United States and Canada, announced that Jannie Oosthuizen, president, Human Health U.S., is scheduled to participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024, at 3:05 p.m. EDT.